Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone

References

• World Health Organization. Adverse events following immunization (AEFI); 2019. Available from: https://www.who.int/vaccine_safety/initiative/detection/AEFI/en/. Accessed July 18, 2023.
   Google Scholar
• Alleman MM, Jorba J, Henderson E, et al. Update on vaccine-derived poliovirus outbreaks—worldwide, January 2020–June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(49):1691–1699. doi:10.15585/mmwr.mm7049a1
   Web of Science ®Google Scholar
• Sierra Leone safeguards children with new vaccine against polio; 2021. Available from: https://www.afro.who.int/news/sierra-leone-safeguards-children-new-vaccine-against-polio. Accessed June 10, 2023.
   Google Scholar
• Yeh MT, Bujaki E, Dolan PT, et al. Engineering the live-attenuated polio vaccine to prevent reversion to virulence. Cell Host Microbe. 2020;27(5):736–751.e8. doi:10.1016/j.chom.2020.04.003
   PubMed Web of Science ®Google Scholar
• Wahid R, Mercer L, Gast C, et al. Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children. NPJ Vaccines. 2022;7(1):19. doi:10.1038/s41541-022-00437-5
   Web of Science ®Google Scholar
• De Coster I, Leroux-Roels I, Bandyopadhyay AS, et al. Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials. Lancet. 2021;397(10268):39–50. doi:10.1016/S0140-6736(20)32541-1
   PubMed Web of Science ®Google Scholar
• MOHS. Housing and Population Census. Demographic and Health Survey. Freetown, Sierra Leone: 2022. Available from: https://www.statistics.sl/index.php/census/census-2015. Accessed February 15, 2023.
   Google Scholar
• Pandey D, Mehta G, Sachdeva M, Tripathi R. Adverse Event Following Immunization (AEFI) in Children: an Analysis of Reporting in VigiAccess. Drug Res. 2022;72(8):435–440. PMID: 35724674. doi:10.1055/a-1852-5335
   Google Scholar
• Huang Y, Song Y, Li J. Survey on Immunization Services for Children with Medical Conditions — China, 2022. China CDC Weekly 5:19; 2023:419–423.
   Google Scholar
• Deoja G, Shanmuganathan P, Kumarappan M. Safety surveillance and causality assessment of adverse event following immunization in children-a vaccine vigilance study. J Physiol Pharm Pharmacol. 2018;8(9):1209. doi:10.5455/njppp.2018.8.0413530042018
   Google Scholar
• Duijster JW, Lieber T, Pacelli S, et al. Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: a Dutch cohort study and review of the literature. Front Immunol. 2023;14:1078736. doi:10.3389/fimmu.2023.1078736
   Web of Science ®Google Scholar
• Hung PV, Nguyen TD, Ha LT, Toi PL, Tram TH. Common Adverse Events from Mixing COVID-19 Vaccine Booster in Hanoi, Vietnam. Vaccines. 2023;11(6):1097. doi:10.3390/vaccines11061097
   Web of Science ®Google Scholar
• Zeitoun A, Hallit S, Chehade S. A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study. J Pharm Policy Pract. 2023;16(24). doi:10.1186/s40545-023-00528-1
   Google Scholar
• Abdu N, Mosazghi A, Yehdego T, Tesfamariam EH, Russom M. Knowledge and perceptions of nurse practitioners on adverse events following immunization and barriers to reporting in the central region, Eritrea: a cross-sectional study. Drug Healthc Patient Saf. 2022;14:125–134. doi:10.2147/DHPS.S363925
   PubMed Web of Science ®Google Scholar
• Parella A, Gold M, Marshall H, Braunack-Mayer A, Watson M. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010. Hum Vaccine Immunother. 2012;8:663–668.
   Web of Science ®Google Scholar
• Thomas F, Abiri OT, Komeh JP, et al. Inconsistent country-wide reporting of adverse drug reactions to antimicrobials in Sierra Leone (2017–2021): a Wake-up call to improve reporting. Int J Environ Res Public Health. 2022;19(6):3264. doi:10.3390/ijerph19063264
   Web of Science ®Google Scholar
• Sebastain J, Gurumurthy P, Ramesh M, Ravi MD. Active surveillance of adverse events following immunization (AEFI): a prospective 3 year vaccine safety study. Therap Adv Vacc Immunother. 2019;7:2515135519889000.
   Google Scholar
• Mittal S, Rawat C, Gupta A, Solanki HK, Singh RK. Adverse events following immunization among children under two years of age: a prospective observational Study From North India. Cureus. 2023;15(4):e38356. doi:10.7759/cureus.38356
   Google Scholar
• Joshi J, Das MK, Polpakara D, Aneja S, Agarwal M, Arora NK. Vaccine safety and surveillance for Adverse Events Following Immunization (AEFI) in India. Indian J Pediatr. 2018;85(2):139–148. doi:10.1007/s12098-017-2532-9
   PubMed Web of Science ®Google Scholar
• Pan X, Lv H, Chen F. Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system. Hum Vaccines Immunother. 2021;17(10):3823–3830. doi:10.1080/21645515.2021.1939621
   PubMed Web of Science ®Google Scholar
• Hu R, Peng S, Guo H. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015–2018. BMC Public Health. 2021;21(1). doi:10.1186/s12889-021-11387-3
   Web of Science ®Google Scholar
• Lombardi N, Crescioli G, Bettiol A, et al. Vaccines safety in children and in General Population:A pharmacovigilance study on adverse events following anti-infective vaccination in Italy. Front Pharmacol. 2019;10. doi:10.3389/fphar.2019.00948
   Web of Science ®Google Scholar
• Ramasubbu SK, Pasricha RK, Nath UK, Dias B. Frequency, nature, severity and preventability of adverse drug reactions arising from cancer chemotherapy in a teaching hospital. J Family Med Prim Care. 2020;9(7):3349–3355. doi:10.4103/jfmpc.jfmpc_352_20
   Google Scholar
• Stokes B. Ministerial Review into the Public Health Response into the Adverse Events to the Seasonal Influenza Vaccine. Perth: Government of Western Australia Department of Health; 2010.
   Google Scholar
• Constantine M, Cremance T, Juru TP, et al. Evaluation of the adverse events following immunization surveillance system in Guruve district, Mashonaland Central 2017. Pan Afr Med J. 2018;31:202. PMID: 31452827; PMCID: PMC6693787. doi:10.11604/pamj.2018.31.202.16573
   Google Scholar
• Duclos P, Hockin J, Pless R, Lawlor B. Reporting vaccine –associated adverse events. Can Fam Physician. 1997;431551:1559–2560.
   Google Scholar
• Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determination of under reporting of Adverse drug reactions. Drug Saf. 2009;32(1):19–31. doi:10.2165/00002018-200932010-00002
   PubMed Web of Science ®Google Scholar
• Meranus D, Stergachis A, Arnold J, Duchin J. Assessing vaccine safety communication with healthcare providers in a large urban county. Pharmacoepidemiol Drug Saf. 2012;21(3):269–275. doi:10.1002/pds.2245
   Web of Science ®Google Scholar